Webhealth Logo

A Network Connecting Healthcare Professionals
WebHealthNetwork Membership: 2,383,423

EN / ES

sign up

log in

Sign Up On Webhealth Network

Sign Up On Jobs At Webhealth Network

LogIn On Webhealth Network

LogIn On Jobs At Webhealth Network

Webhealth Logo
  • Home
  • HealthCare Directory
    • US Medical Doctor Directory
    • US Nurse Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Research Articles
  • Videos
  • Solutions
  • Jobs
    • Search For Jobs Post A Job
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

AML With Myelodysplasia-related Features - 28 Studies Found

Status Study
Recruiting Study Name: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Date: 2016-01-14
Interventions: Drug: Cytarabine Given IV
Recruiting Study Name: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Date: 2014-03-11
Interventions: Drug: clofarabine Given IV
Recruiting Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Date: 2014-02-24
Interventions: Drug: eltrombopag olamine Given PO Other Names:
Terminated Study Name: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Date: 2014-01-06
Interventions: Drug: cytarabine Given SC
Active, not recruiting Study Name: Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Date: 2012-10-08
Interventions: Drug: decitabine Given IV
Withdrawn Study Name: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia
Date: 2012-07-20
Interventions: Drug: cyclophosphamide Given I
Completed Study Name: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Adult Acute
Date: 2012-03-28
Interventions: Drug: tosedostat Given PO
Terminated Study Name: Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Date: 2011-10-10
Interventions: Drug: bortezomib Given SC Other Names:
Completed Study Name: Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Date: 2011-05-06
Interventions: Drug: alvocidib Given IV
Completed Study Name: Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk
Date: 2010-11-04
Interventions: Procedure: standard follow-up care
Page 1 of 3
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy
  • Sitemap

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.